About the event: Contrary to pervasive stereotypes, eating disorders affect people of all body sizes—in fact, less than 6% of people with eating disorders are underweight. Still, people in large bodies who are struggling with eating disorders continue to go undiagnosed or are misdiagnosed, and face stigma and weight bias if they do seek treatment.
During this presentation, attendees will learn to describe the dangers of weight bias and myths in eating disorder treatment, as well as summarize key considerations for large patients and strategies for helping patients embrace weight-inclusivity. The discussion, led by Savannah Erwin, PhD, Senior Program Development Lead at Equip, and Ally Duvall, Senior Program Development Lead at Equip, will bring in research, data, and stories from real patients to fully explore this complex topic. Registrants of this event will receive a take-home resource to put these learnings into practice.
Learning objectives: After participating in this session, attendees should be able to:
- Recognize three common weight myths and dangers of weight bias in different eating disorder diagnoses.
- Name three key factors to consider for large patients in eating disorder treatment.
- Describe three strategies that providers can use with patients who are hesitant to adopt weight inclusivity.
Ally Duvall is a fat activist and eating disorder professional currently serving as Senior Program Development Lead at Equip. She drives innovation across eating disorder treatment by designing evidence-based programming that enables multidisciplinary teams to deliver accessible, scalable clinical care. Her background spans cognitive dissonance-based interventions, body image programming, and weight-neutral adaptations, integrating lived recovery experience, and bridging the gap between research-backed treatments and real-world clinical practice. In addition to her program work, Ally delivers clinical trainings, presents at conferences nationwide, and has published work in both peer-reviewed journals and major media outlets.
Dr. Savannah Erwin is a licensed clinical psychologist specializing in eating disorder treatment and evidence-based clinical program development. With experience spanning the full continuum of care, Dr. Erwin focuses on designing and scaling accessible, high-impact interventions for individuals and families across the lifespan. As Senior Program Development Lead at Equip Health, she oversees the creation and implementation of virtual care designed to expand access to effective, evidence-based care. Dr. Erwin completed a postdoctoral fellowship at the University of North Carolina (UNC) Center of Excellence for Eating Disorders after earning her PhD in clinical psychology from Duke University.
Registration cost:Free
Following your event attendance, you’ll receive an email from TPN.health prompting you to complete your evaluation. The evaluation will be located in your TPN.health account under CE Wallet evaluations. Once the evaluation is complete, you’ll receive the CE which will also live in your CE Wallet under certificates.
Physicians, nurses, dietitians, nutritionists, psychologists, social workers, marriage and family therapists, addiction counselors, and counselors are all eligible for CE or CME credit. For other credentials interested in CEs, please review the CE Details page within the TPN.health registration page to confirm that you’ll receive CEs.
While slides won’t always be shared, any shared slides will be made available on the event page under resources. During the presentation we’ll indicate whether slides will be shared or not.
When you click the “register via TPN.health” button, you’ll be rerouted to the registration page on TPN’s website. If you don’t have a TPN account, you will be prompted to create one for free. Your membership will remain active and free!
After registering for the webinar, you will receive an email from TPN.health with instructions and a link to join. You can also access the event by logging into your TPN.health account, under CE Wallet and My Education.
Additional CE information
Refund policy: This activity is offered free of charge.
Target audience: The target audience for this presentation includes medical doctors, nurse practitioners, registered dietitians, therapists, case managers, and other health care providers.
Learning format / activity type: Live activity
Continuing Education accreditation:
APA: Equip is approved by the American Psychological Association to sponsor Continuing Education for psychologists. Equip maintains responsibility for this program and its content.
ACCME: Equip is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Other healthcare professionals: We are happy to provide a certificate of attendance for all providers who stayed for the duration of the activity, however, it is up to the individual attendee to determine whether this activity meets the Continuing Education requirements of their licensing or credentialing organization. Please check your state’s rules and regulations for more information regarding your Continuing Education requirements.
Attendance: Full attendance is required to earn Continuing Education credit through the APA. It is up to each individual attendee to determine whether this activity meets the Continuing Education requirements of their licensing or credentialing organization. Please check your state’s rules and regulations for more information regarding your Continuing Education requirements.
Disclosures:
- Equip receives no commercial funding for these activities.
- The presenter(s) mentioned above, faculty for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose. Natalia Orloff, PhD, Jessie Menzel, PhD, and Angela Celio Doyle, PhD, FAED, planners for this educational activity, have no relevant financial relationships with ineligible companies to disclose.
- Maria La Via, MD, planner for this educational activity, owns individual stock in the following ineligible companies: Danahar, Gilead, 3M, GSK, Merck, Seres Therapeutics, Solventum, Novavax, Organon, Pfizer, and Viatris. All of the relevant financial relationships listed for these individuals have been mitigated.
